Pharmaceutical Technology Europe
A Strengths, Weaknesses, Opportunities and Threats analysis of the biosimilars market is given.
Anjan Selz
Advertisement
Anjan Selz is CEO at Finox AG
Articles by Anjan Selz
Advertisement
Latest Updated Articles
- A SWOT Analysis Of The Biosimilars Market
September 1st 2010
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
PharmTech Weekly Roundup—June 19, 2026
5